Absorption of epi-doxorubicin after intravesical administration of patients with in situ transitional cell carcinoma of the bladder
- 13 May 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (5) , 505-508
- https://doi.org/10.1016/0277-5379(87)90310-5
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Prophylactic use of topical adriamycin after transurethral resection of transitional cell bladder tumoursInternational Urology and Nephrology, 1985
- The Absorption of Doxorubicin and Mitomycin C in Perioperative InstillationEuropean Urology, 1985
- Adjuvant Chemotherapy of Superficial Transitional Cell Bladder Carcinoma:Preliminary Results of a European Organization for Research onTreatment of Cancer Randomized Trial Comparing Doxorubicin Hydrochloride, Ethoglucid and Transurethral Resection AloneJournal of Urology, 1984
- Intravesical doxorubicin for the prophylaxis of superficial bladder tumors. A multicenter studyCancer, 1984
- Intracavitary Doxorubicin Hydrochloride Therapy for Carcinoma in Situ of the BladderJournal of Urology, 1981
- Studies on the Intravesical Action of Topically Administered G 3 H-Doxorubicin Hydrochloride in Men: Plasma Uptake and Tumor PenetrationJournal of Urology, 1980
- Rationale for Intensive Intravesical Chemotherapy for Superficial Bladder CancerJournal of Urology, 1980
- Intravesical Therapy with Adriamycin in Patients with Superficial Bladder TumorsEuropean Urology, 1980
- Topical Instillation of Doxorubicin Hydrochloride in the Treatment of Recurring Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, 1977
- Permeability of the bladder mucosa to thiotepa, adriamycin, and daunomycin in men and rabbitsUrological Research, 1976